Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000674694 | SCV000800080 | likely pathogenic | Nemaline myopathy 2 | 2018-05-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000674694 | SCV001588154 | pathogenic | Nemaline myopathy 2 | 2024-01-28 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu7415Lysfs*2) in the NEB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NEB are known to be pathogenic (PMID: 25205138). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with NEB-related conditions. ClinVar contains an entry for this variant (Variation ID: 558429). For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV001784296 | SCV002017926 | likely pathogenic | not provided | 2023-01-13 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003472174 | SCV004200266 | likely pathogenic | Arthrogryposis multiplex congenita 6 | 2023-05-29 | criteria provided, single submitter | clinical testing |